ADVS Stock UPDATES Advent Software (ADVS) 31.93 08/02/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Advent Software (ADVS) 31.93 $ADVS

12.4% Return Seen to Date on SmarTrend Advent Software Call (ADVS)
Comtex SmarTrend(R) - Wed Jul 30, 10:06AM CDT
SmarTrend identified an Uptrend for Advent Software (NASDAQ:ADVS) on May 27th, 2014 at $29.97. In approximately 2 months, Advent Software has returned 12.36% as of today's recent price of $33.67.

Why Advent Software (ADVS) Stock Is Surging
at The Street - Tue Jul 29, 11:43AM CDT
Shares of Advent Software (ADVS) are soaring to a six month high after posting upbeat second quarter results.

Advent Soars, Integrated Leaps: Tech Winners & Losers
at The Street - Tue Jul 29, 11:03AM CDT
Several software companies' share prices jumped on strong quarterly earnings, while Oracle shares rose slightly after cutting CEO Larry Ellison's stock compensation.

ADVENT SOFTWARE
at Investor's Business Daily - Mon Jul 28, 5:49PM CDT
ADVENT SOFTWARE (ADVS), a maker of investment-management tools for financial professionals, said that Q2 EPS fell 11% to 33 cents, topping views by a penny. Revenue rose 4% to $100.37 mil, beating views for $97.8 mil.

Advent Software Reports Second Quarter 2014 Results
Marketwire - Mon Jul 28, 3:20PM CDT
Advent Software, Inc. (NASDAQ: ADVS), a leading provider of software and services to the global investment management industry, announced today its financial results for the second quarter ended June 30, 2014.

Advent Software to Present at InvestMNt Conference on August 6, 2014
Thomson Reuters ONE - Thu Jul 24, 3:16PM CDT
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

YieldBoost ADVS From 1.6% To 11.7% Using Options
StockOptionsChannel.com - Tue Jul 22, 10:39AM CDT
Shareholders of Advent Software, Inc. looking to boost their income beyond the stock's 1.6% annualized dividend yield can sell the November covered call at the $35 strike and collect the premium based on the $1.10 bid, which annualizes to an...

Advent Software to Release Second Quarter Results for 2014 on Monday, July 28, 2014
Thomson Reuters ONE - Mon Jul 14, 11:31PM CDT
SAN FRANCISCO - July 14, 2014 - Advent Software, Inc. (NASDAQ: ADVS), a leading provider of software and services to the global investment management industry, announced today that it will release its financial results for the second quarter ended June 30, 2014 on Monday, July 28, 2014 after the market closes.

Blackbaud's eTapestry Offers Analytics for Non-Profitable Firms - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 10:00AM CDT
Blackbaud Inc. (BLKB) recently launched an upgrade to its cloud-based solution- eTapestry CRM to incorporate the automated data services from its Target Analytics division.

58.com (WUBA) Soars: Stock Rises 13.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 8:39AM CDT
58.com Inc. (WUBA) was a big mover last session, as its shares rose nearly 14% on the day.

Pitney Bowes, DocuConsulting Join to Modernize Insurance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 10:00AM CDT
Pitney Bowes Inc. (PBI) recently collaborated with DocuConsulting - a professional services firm specializing in customer communications management.

Concur's Perfect Trip Initiative Shows Potential - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 5:00PM CDT
On Jun 20, 2014, we issued an updated research report on Concur Technologies Inc. (CNQR).

Neonode (NEON) Crumbles: Stock Falls by 5.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:45AM CDT
Neonode, Inc. (NEON) saw a big move last session,continuing the recent downtrend for NEON, as the stock is now down more than 26% in the past one-month time frame

Pitney Bowes' Direct Mail Extension Fails to Impress - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 4:45PM CDT
Pitney Bowes Inc. (PBI) recently announced that it will be investing to extend its direct mail presorting service to the Southeast U.S.

Pitney Bowes, Broadridge Launch Inlet - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 11:00AM CDT
On Jun 9, Pitney Bowes Inc. (PBI) announced a joint venture with Broadridge Financial Solutions, Inc. (BR) to launch Inlet - a novel technology platform.

Advent Wins "Best Portfolio Management Solution" at WealthBriefing European Awards 2014
Marketwire - Thu Jun 05, 1:53AM CDT
Advent Software, Inc. (NASDAQ: ADVS), a leading provider of software and services for the global investment management industry, today announced that Advent Portfolio Exchange(R) (APX) was awarded "Best Portfolio Management Solution" at the WealthBriefing European Awards 2014.

Advent Wins 2014 FTF News Technology Innovation Award
Marketwire - Thu Jun 05, 1:43AM CDT
Advent Software, Inc. (NASDAQ: ADVS), a leading provider of software and services for the global investment management industry, today announced that Advent Portfolio Exchange(R) (APX) was awarded "Best Client Reporting Solution" in the FTF News Technology Innovation Awards. Presented by the Financial Technologies Forum and FTF News, the awards recognize professionals, financial technology vendors, service providers, industry bodies, and regulators that made significant strides and realized noteworthy achievements in operational excellence in 2013.

Advent's Black Diamond Platform Surpasses 500-Client Milestone
Marketwire - Wed Jun 04, 10:59AM CDT
Advent Software, Inc. (NASDAQ: ADVS), a leading provider of software and services for the global investment management industry, today announced that Black Diamond, an independent business group of Advent, has surpassed 540 clients and exceeded $245 billion in assets on its portfolio management, reporting, and rebalancing platform. The Black Diamond platform has increased its client base by more than 125 percent and assets on the platform by more than 240 percent since its acquisition by Advent in June 2011.

Advanced Energy (AEIS) Falls: Stock Goes Down 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 04, 7:52AM CDT
Shares of Advanced Energy fell about 7% last session and down nearly 17% in the past one-month time frame, suggests that it requires a close watch of this firm in the near future.

Neonode (NEON) Crumbles: Stock Falls by 11.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 03, 7:57AM CDT
Neonode, Inc. (NEON) saw a big move last session,continuing the recent downtrend for NEON, as the stock is now down more than 37% in the past one-month time frame.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading

Top 5 Most Recently Viewed Articles

Meiji Seika Pharma Expands KOSTAIVE® Manufacturing In Japan

Updated Category News Views 394

Meiji Seika Pharma Enhances Manufacturing Capabilities Meiji Seika Pharma Co., Ltd., known for its commitment to healthcare, has recently received exciting approval to expand its manufacturing and marketing capabilities for the innovative self-amplifying mRNA vaccine, KOSTAIVE®. This decision marks a significant milestone for the company as it strengthens the local...

Continue Reading
OS Therapies Achieves Milestone in Osteosarcoma Treatment

Updated Category News Views 246

An Exciting Breakthrough in Osteosarcoma Treatment OS Therapies, Inc. (NYSE-A: OSTX), a pioneering biotechnology firm, has recently made waves in the oncology field by completing a Phase 2b clinical trial concerning its innovative treatment, OST-HER2. This trial aims to address the severe challenges faced by patients suffering from lung metastatic osteosarcoma - a rare...

Continue Reading
CEO Andy Byron Takes Leave Following Coldplay Concert Incident

Updated Category News Views 381

CEO Andy Byron Takes Leave Amidst Viral Coldplay Incident Astronomer CEO Andy Byron is currently on leave due to a controversial situation that unfolded during a Coldplay concert. A video that circulated online appears to show Byron embracing the company’s HR head, Kristin Cabot, which ignited a social media frenzy. The Viral Video's Impact The footage, which originated...

Continue Reading
Misunderstood Whiskey's Exciting Launch of Orange Blossom Bourbon

Updated Category News Views 234

Misunderstood Whiskey Launches Orange Blossom Bourbon Misunderstood Whiskey Co. has announced the launch of their eagerly awaited Orange Blossom Bourbon. This marks a significant milestone as it is the brand's first bourbon since it began in 2017. With this release, the company aims to revolutionize the flavored whiskey market by providing high-quality, infused options...

Continue Reading
Impact of Capital Flows on Emerging Markets: A Cautionary Analysis

Updated Category News Views 352

Capital Flow Challenges for Emerging Economies The dynamics of capital flows have become a significant topic of discussion lately, with emerging markets facing potential hurdles that could alter their financial landscape dramatically. Recent insights from JPMorgan, an influential investment bank, shed light on these pressing issues. As economic policies shift globally,...

Continue Reading